3.32
Ani Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−31.2
FY23:
119
FY24:
64.0
FY25:
185
Change from FY21 to FY25
millions USD
FY21:
−105
FY22:
−15.7
FY23:
−18.5
FY24:
−405
FY25:
−34.3
Change from FY21 to FY25
millions USD
FY21:
195
FY22:
−5.13
FY23:
67.4
FY24:
265
FY25:
−9.94
millions USD
FY21:
92.4
FY22:
−52.1
FY23:
168
FY24:
−76.2
FY25:
141
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.77
FY22:
−40.1
FY23:
110
FY24:
47.8
FY25:
171
All amounts in millions USD